About Karup Pharma Private Limited
Data last updated:
Karup Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 May 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24220TG2005PTC046181. Its GSTIN is 36AACCK5933B1ZT (Telangana).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Uma Devi Varigonda and Varigonda Veekshitha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ole Gsi Park, Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.13 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹95,612 (net margin 0.8%) and EBITDA of ₹5.02 Lakh (EBITDA margin 4.4%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹3.86 Cr and satisfied charges of ₹20 Lakh on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website karuuppharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressHn 12 – 1 – 2/49 Ist Floor Raghavendra Nagar Bandlguda Nag, Ole Gsi Park, Hyderabad, Telangana, India
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Karup Pharma Private Limited
The main business activities of Karup Pharma are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Karup Pharma Private Limited FY 2025 filings available
Karup Pharma Private Limited reported revenue of ₹1.13 Cr (up 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Karup Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 11% growth in the latest year. EBITDA fell 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Karup Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹5.02 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹95,612 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Karup Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Karup Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Karup Pharma Private Limited
Karup Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kapsin Pharma Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Ahmedabad, Gujarat, India |
| Medixfora Healthcare Private Limited | ₹1.14 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Gurgaon, Haryana, India |
| Coz Drug Marketing Services Private Limited | ₹1.13 Cr (FY 2024) | •••• | •••• | -10.0% | •••• | Lucknow, Uttar Pradesh, India |
| Sam Marino Labs Private Limited | ₹1.13 Cr (FY 2024) | •••• | •••• | 23.0% | •••• | Lucknow, Uttar Pradesh, India |
| Us Lifecare Private Limited | ₹1.13 Cr (FY 2017) | •••• | •••• | -9.0% | •••• | Vadodara, Gujarat, India |
| Karup Pharma Private Limited this company | ₹1.13 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Hyderabad, Telangana, India |
| Mmred Bio Private Limited | ₹1.13 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Hyderabad, Telangana, India |
| Kadam Pharma Private Limited | ₹1.13 Cr (FY 2025) | •••• | •••• | -88.0% | •••• | Aurangabad, Maharashtra, India |
| Index Therapeutics Private Limited | ₹1.13 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | Hyderabad, Telangana, India |
| Davabikri Solution Private Limited | ₹1.12 Cr (FY 2025) | •••• | •••• | -29.0% | •••• | Faridabad, Haryana, India |
| Ambiens Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2025) | •••• | •••• | 119.0% | •••• | Csa, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Karup Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Karup Pharma Private Limited
Karup Pharma Private Limited is audited by V V L & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V V L & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Karup Pharma Private Limited
Karup Pharma has 5 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uma Devi Varigonda | Director | 10 May 2005 | 21 Years 5 Months | Current |
| Varigonda Veekshitha | Director | 23 Nov 2020 | 5 Years 10 Months | Current |
| Kiranteja Varigonda | Director | 23 Nov 2020 | 5 Years 10 Months | Current |
| Radha Krishna Varigonda | Director | 10 May 2005 | 21 Years 5 Months | Current |
| Pavan Teja Varigonda | Director | 04 Mar 2022 | 4 Years 7 Months | Current |
Ownership and Shareholding of Karup Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Karup Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jun 2022 | Others | ₹3.86 Cr | Open |
| 10 Mar 2006 | Syndicate Bank | ₹20 Lakh | Satisfied |
Total charge records: 2 View all charges
Legal Cases of Karup Pharma Private Limited
Karup Pharma Private Limited has 1 court case on record: 1 filed against it. All case is pending. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Medchal Malkajgiri, Telangana | Civil suit | Filed against the company by Rite-Aid Labs Private Limited | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Karup Pharma Private Limited
Employment history and EPFO contributions of people linked to Karup Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Karup Pharma Private Limited
Karup Pharma has one previous CIN (Corporate Identification Number): U24220AP2005PTC046181. The current CIN is U24220TG2005PTC046181, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24220TG2005PTC046181 | Current |
| U24220AP2005PTC046181 | Previous |
Recent Activity on Karup Pharma Private Limited
Karup Pharma Private Limited has 7 board changes on record since 2005: 5 appointments and 2 cessations. The latest: Pavan Teja Varigonda was appointed as Director on 04 Mar 2022.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Karup Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Karup Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Karup Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Karup Pharma Private Limited
Karup Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AACCK5933B1ZT | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Karup Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Karup Pharma Private Limited
Karup Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 May 2005 (21+ years old) and is registered under CIN U24220TG2005PTC046181.
Karup Pharma reported revenue of ₹1.13 Cr for FY 2024 (up 11% YoY).
Karup Pharma has 5 current directors:
- Uma Devi Varigonda - Director
- Varigonda Veekshitha - Director
- Kiranteja Varigonda - Director
- Radha Krishna Varigonda - Director
- Pavan Teja Varigonda - Director
Karup Pharma reported a net profit of ₹95,612 (net margin 0.8%) and EBITDA of ₹5.02 Lakh (EBITDA margin 4.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Karup Pharma is 28% over three years and 4% over five years. In the latest year (FY 2024) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Karup Pharma is 36AACCK5933B1ZT, registered in Telangana.
The CIN (Corporate Identification Number) of Karup Pharma is U24220TG2005PTC046181. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Karup Pharma has 1 court case on record: 1 filed against it. 1 is pending.
Karup Pharma was incorporated on 10 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Karup Pharma by revenue are Kapsin Pharma Private Limited, Medixfora Healthcare Private Limited, Coz Drug Marketing Services Private Limited, Sam Marino Labs Private Limited, Us Lifecare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Pavan Teja Varigonda was appointed as Director on 04 Mar 2022. Kiranteja Varigonda ceased to be Additional Director on 31 Dec 2020. Varigonda Veekshitha ceased to be Additional Director on 31 Dec 2020. Karup Pharma has 7 board changes on record in total.